Pancreas Cancer Clinical Trials

Pancreas Cancer studies recruiting patients for novel treatments. Filter by phase, distance, and inclusion criteria to find your perfect pancreas cancer clinical trial.

Filter Clinical TrialsFilter Clinical Trials

LOCATION

Anywhere

FILTER TRIALS

Randomized Clinical Trial Investigating Multidimensional Prehabilitation in Pancreatic Surgery for participants with Pancreatic and Periampullary Neoplasms

This study is evaluating whether alectinib may be effective for individuals with certain types of cancer.

anti-EGFR-bispecific antibody armed activated T-cells

This study is evaluating whether a type of white blood cell called T-cells, which have been modified to attack cancer cells, may help treat pancreatic cancer.

Phase Ia - Explore safety and establish the maximum tolerated dose (MTD)/recommended dose levels for phase Ib expansion phase of BI 905711 based on the frequency of patients experiencing dose limiting toxicities (DLTs) during the MTD evaluation period. The MTD evaluation period is defined …

This study is evaluating whether a drug may help treat cancer.

Gemcitabine - 28 day cycle

This study is evaluating whether a drug which blocks a certain protein may help treat cancer.

This study is evaluating whether a combination of chemotherapy drugs may help treat pancreatic cancer.

This study is evaluating whether nab-paclitaxel in combination with gemcitabine can prevent or delay recurrence of pancreatic cancer.

This study is evaluating whether high dose ascorbate is safe for people with pancreatic cancer.

This study is evaluating whether a new drug can be used to treat cancer patients who have a specific genetic mutation.

This clinical trial is evaluating a drug called BT8009 alone and in combination with nivolumab in participants with advanced solid tumors associated with Nectin-4 expression or in participants with advanced solid tumor malignancies having renal insufficiency. The main goals of this study …

This is a research study to evaluate how the genetic makeup of Pancreatic Ductal Adenocarcinoma (PDAC) can affect the response to FDA-approved chemotherapy treatment, FOLFIRINOX, given before surgery to remove the tumor. Certain types of PDAC tumors can be surgically resected (removed). Ho…

This study will enroll patients who have metastatic pancreatic cancer and have progressed on prior chemotherapy. Part 1 (dose escalation) participants will receive epacadostat/pembrolizumab/cyclophosphamide(CY)/GVAX pancreas vaccine followed by epacadostat/pembrolizumab/CRS-207, Part 1X (…

This study is evaluating whether high doses of vitamin C may help improve survival for individuals with pancreatic cancer.

RATIONALE: Pancreas tumor localization makes minimally invasive surgical resection of pancreas tumors very challenging. Recently, an endoscopic ultrasound needle system has been developed which enables fiducial coils to be placed at the precise site of biopsy. INTERVENTION: At time of EUS…

EUS enhanced with contrast to evaluate pancreas

RATIONALE: Endoscopic Ultrasound (EUS) is the leading method to evaluate the pancreas but there may be difficulty characterizing small lesions, tumors which are not adenocarcinomas and neoplasia in the setting of pancreatitis. INTERVENTION: The innovation in this project will be the addit…

GMCI (aglatimagene besadenovec + valacyclovir)

This study is evaluating whether a combination of radiation and chemotherapy followed by surgery and a transfusion of white blood cells may help treat pancreatic cancer.

This study is evaluating whether a vaccine therapy and sargramostim can be safely given together to treat patients with pancreatic cancer.

NUV-868-01 is a first-in-human, open-label, Phase 1/2 dose escalation and expansion study in patients with advanced solid tumors. The Phase 1 and 1b portions include patients with advanced solid tumors and are designed to determine the safety and the dose of NUV-868 to be used as monothera…

Mesenchymal Stromal Cells-derived Exosomes with KRAS G12D siRNA

This study is evaluating whether a new treatment for pancreatic cancer may be effective.

Stereotactic Radiosurgery

This study is evaluating whether CyberKnife radiosurgery plus chemotherapy is more effective than chemotherapy alone for the treatment of potentially resectable adenocarcinoma of the pancreas.

5FU, leucovorin, oxaliplatin

Chemotherapy is often used to help shrink the cancer temporarily and may improve survival for patients with incurable pancreas cancer that has spread to other organs. In Canada, the gemcitabine chemotherapy is used to treat pancreas cancer that has spread. The combination of oxaliplatin wi…

Chemotherapy is given after curative surgery for pancreas cancer to try to improve cure rates. There are two choices of chemotherapy which are currently considered equal treatments: gemcitabine or 5-fluorouracil (5FU). This study is trying to determine if one of two standard chemotherapies…

Standard Dose Acclerated Fraction Radiotherapy

This study is evaluating whether a new treatment for pancreatic cancer is safe and effective.

cisplatin, gemcitabine, interferon-alpha

Thermal therapy (hyperthermia, or heat) enhances the chemotherapy anti-tumor kill. Thermal therapy by itself also kills cancer cells. Whole-body thermotherapy is a systemic treatment that includes the entire body. By using fever-range whole-body thermal therapy, cancer cells can be treated…

Unbiased Results

We believe in providing patients with all the options.

Your Data Stays Your Data

We only share your information with the clinical trials you're trying to access.

Verified Trials Only

All of our trials are run by licensed doctors, researchers, and healthcare companies.

Power

Pancreas Cancer Clinical Trials

Pancreas Cancer studies recruiting patients for novel treatments. Filter by phase, distance, and inclusion criteria to find your perfect pancreas cancer clinical trial.

Relevant Clinical Trials

Top Oncology Trials

Popular Clinical Trials